Cengiz Karacin

22PUBLICATIONS
155CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Midwifery not elsewhere classifiedMolecular targetsPredictive and prognostic markersRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Nov 17, 2025
Real-world comparison of doxorubicin-ifosfamide versus gemcitabine-docetaxel regimens in metastatic uterine leiomyosarcoma: a multicenter retrospective study.

Salih Tunbekici, Gokhan Sahin, Haydar Cagatay Yuksel

|Oct 24, 2025
Investigation of the prevalence of HER2-ultralow and the effects of HER2 status (HER2-null vs. HER2-ultralow) on survival in HER2-negative early-stage breast cancer.

Alper Türkel, Sultan Çiğdem Irkkan, İlknur Deliktaş Onur

|Sep 19, 2025
Real-world comparison of cabozantinib and sunitinib in advanced non-clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group.

Gökhan Şahin, Esmanur Kaplan Tüzün, Halil G Güzel

|Nov 26, 2024
Evaluation of CDK4/6 inhibitors in first-line in symptomatic and asymptomatic patients with metastatic breast cancer.

İrem Öner, Alper Türkel, Hicran Anık

|Oct 25, 2024
Monitoring the Response of Cyclin-Dependent Kinase 4/6 Inhibitors with Mean Corpuscular Volume.

Bediz Kurt İnci, Pınar Kubilay Tolunay, Şura Öztekin

|Aug 14, 2024
Trastuzumab-induced optic neuritis: "blindness" side effect.

Tuğba Önder, Cengiz Karaçin

Pageof 4

Frequent Collaborators

6 joint publications

Yakup Ergun

4 joint publications

Alper Türkel

3 joint publications

Ozan Yazıcı

3 joint publications

Omur Berna Oksuzoglu